Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry

Anas Younes: How MRD Testing Is Advancing Hematology Care

Myeloma Paper of the Day, July 8th, Suggested by Robert Orlowski

European Multiple Myeloma Patients Face Unequal Access to Curative Treatments

At the European Hematology Association (EHA) 2026 Congress in Stockholm, speakers highlighted that while new drugs and treatment combination

Plasma proteomic signatures enable risk prediction of early retinal neurodegeneration in type 2 diabetes

This multi-cohort prospective observational study by Wei Wang and colleagues investigates circulating plasma protein signatures associated w

Consensus statement on mass spectrometry-based proteomic analysis of cardiac tissue

Proteomic and phosphoproteomic profiling reveals melanoma cell responses to T cell attack

This study profiles the early proteomic and phosphoproteomic responses of patient-derived melanoma cells when co-cultured with matched autol